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Atherosclerotic	cardiovascular	disease	is	a	global	health	
problem.	Many	published	statistics	have	shown	correspon-
dence	of	a	large	disease	burden	with	the	economic	burden	
attributed	to	atherosclerotic	cardiovascular	disease.	Better	
identification	of	asymptomatic	individuals	at	high	risk	for	
coronary	artery	disease	(CAD)	to	receive	aggressive	risk	re-
duction	therapy	is	an	important	challenge	for	the	primary	
prevention	of	cardiovascular	disease.	CAD	is	known	to	in-
volve	a	prolonged	asymptomatic	phase.	Frequently,	the	first	
clinical	presentation	of	CAD	results	in	serious	morbidity	or	
mortality,	and	approximately	50%	of	all	acute	coronary	syn-
dromes	(ACS)	occur	in	previously	asymptomatic	subjects.
1)	
In	addition,	despite	the	etiologic	importance	in	atheroscle-
rosis,	cardiovascular	risk	factors	have	been	shown	to	poorly	
predict	asymptomatic	subjects	of	the	risks	of	developing	
CAD.
2)
Recently,	sophisticated	imaging	technology	has	been	de-
veloped	and	several	imaging	modalities	are	used	as	good	sc-
reening	tools	to	identify	patients	at	high	risk	for	cardiovascu-
lar	disease.	Commonly	used	non-invasive	atherosclerosis	im-
aging	techniques	in	the	clinical	setting	include	carotid	intima-
media	thickness	and	plaque	measured	by	ultrasound;	coro-
nary	artery	calcium	as	detected	by	cardiac	computed	tomogra-
phy;	ankle-brachial	index	as	measured	by	distal	pressure	Dop-
pler	measurement;	and	the	aortic	pulse	wave	velocity	as	meas-
ured	by	carotid	and	femoral	pressure	wave	recordings	with	a	
Doppler	or	mechanographic	device.
3)	Simon	et	al.
4)	compared	
the	prognostic	performance	of	subclinical	atherosclerosis	
tests	in	predicting	CAD	in	asymptomatic	individuals.	Positive	
testing	for	subclinical	atherosclerosis	is	associated	with	a	
moderately	high	to	high	CAD	risk.	However,	different	types	
of	subclinical	atherosclerosis	tests	differ	in	their	prognostic	
performances.	It	is	recognized	that	a	“detection	gap”	exists,	de-
fined	as	the	difference	between	CAD	cases	or	events	current-
ly	detected	and	the	total	burden	of	disease	or	events	among	
the	population.
5)
Multi-slice	coronary	computed	tomography	angiography	
(CCTA)	has	emerged	as	a	very	attractive,	non-invasive	diagnos-
tic	modality	to	visualize	the	coronary	arteries,	including	the	lo-
cation,	severity,	and	characteristics	of	atherosclerotic	plaque.
6)	
Because	CCTA	comprehensively	evaluates	the	composition	
(calcific	and	non-calcific)	of	coronary	plaques,	CCTA	may	
provide	prognostic	evidence	independent	of,	and	incremen-
tal	to,	CT	calcium	scoring.	CCTA	can	assess	the	presence	of	
subclinical	atherosclerosis	and	may	be	a	useful	tool	for	early	
CAD	detection	in	asymptomatic	subjects.
Although	many	studies	have	demonstrated	the	diagnostic	
or	prognostic	value	of	CCTA	in	significant	CAD,	such	studies	
in	asymptomatic	subjects	are	limited.
7-9)	Choi	et	al.
7)	assessed	
the	value	of	CCTA	as	a	screening	tool	for	the	detection	of	oc-
cult	CAD	in	1,000	asymptomatic	Korean	subjects.	Specifi-
cally,	22%	of	individuals	had	detectable	coronary	atheroscle-
rosis,	but	only	5%	had	significant	stenoses.	Coronary	events	
occurred	in	individuals	with	detectable	plaques,	but	most	of	
them	were	revascularizations	triggered	by	the	fact	that	an	
atherosclerotic	lesion	had	been	detected.	Similarly,	although	
a	26-36%	prevalence	of	significant	CAD	was	detected	in	as-
ymptomatic	type	2	diabetic	patients,
8)9)	the	prognostic	value	
of	these	observations	are	uncertain	due	to	a	lack	of	follow-
up.	Moreover,	the	precise	role	of	CCTA	in	the	diagnostic	work-
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up	of	patients,	even	those	with	suspected	CAD	in	relation	to	
existing	non-invasive	functional	tests	(electrocardiogram-
stress	test,	stress-single	photon	emission	CT,	or	dobutamine	
echocardiography),	has	not	been	established.
In	a	recent	review,	Lee	et	al.
10)	also	assessed	the	role	of	
CCTA	in	identifying	subclinical	CAD	in	4,320	asymptomat-
ic	Korean	individuals.	It	seemed	to	be	an	extension	of	a	pre-
vious	study
7)	with	a	larger	population	at	the	same	institute.	
They	showed	similar	results,	that	coronary	artery	plaques	were	
present	in	24%	of	individuals	and	significant	CAD	was	iden-
tified	in	only	3%	of	subjects.	While	it	was	encouraging	that	a	
challenging	study	with	a	large	population	was	conducted	in	
Korea,	several	limitations	and	concerns	were	raised	in	this	
study.	First,	because	there	were	no	confirmative	data	in	CAD	
and	no	follow-up	data,	they	could	not	prove	a	definite	role	for	
CCTA	in	risk	stratification	or	prognosis.	Second,	there	existed	
patient	bias.	Although	they	were	referred	for	general	health	
evaluation,	only	20%	of	patients	underwent	CCTA	for	fur-
ther	cardiac	evaluation	for	clinical	reasons.	Specifically,	in	men,	
more	than	50%	belonged	to	the	moderate-	and	high-risk	gr-
oups.	Detection	of	significant	CAD	may	have	been	lower	if	CC-
TA	was	performed	blindly	in	an	asymptomatic	population.	
Third,	they	did	not	perform	multivariate	analysis	for	CAD,	in-
cluding	age,	gender,	and	various	co-morbidities,	and	it	was	
therefore	difficult	to	define	an	independent	or	additive	role	for	
CCTA	in	risk	stratification	of	CAD.
In	addition,	when	considering	the	current	use	of	CCTA	for	
risk	stratification	in	asymptomatic	individuals,	injection	of	
the	mandatory	contrast	agent	and	exposing	patients	to	sub-
stantially	higher	radiation	doses	compared	to	coronary	cal-
cium	measurements	must	be	taken	into	account.	The	Amer-
ican	College	of	Cardiology	recently	endorsed	a	list	of	ap-
propriate	uses	for	CCTA.	Specifically,	CCTA	is	currently	not	
recommended	for	risk	stratification	and	screening	in	asymp-
tomatic	populations,	due	to	lack	of	favorable	prognostic	data	
in	asymptomatic	individuals.
11)
It	is	still	debated	whether	and	how	subclinical	atheroscle-
rosis	should	be	treated.	Recently,	statin	therapy	has	been	shown	
to	delay	the	progression	of	atherosclerosis	in	clinical	studies.
12)	
In	the	Multi-Ethnic	Study	of	Atherosclerosis	(MESA)
13)	among	
adults	with	high	coronary	calcium	scores,	95%	remained	as-
ymptomatic	over	the	subsequent	5	years,	and	most	people	with	
abnormal	findings	on	screening	will	remain	disease	free.	An-
other	concern	is	that	asymptomatic	healthy	subjects	may	turn	
into	“patients”	with	occult	coronary	atherosclerosis,	which	may	
trigger	anxiety	and	result	in	further	diagnostic	procedures	and	
unnecessary	treatment.
Taylor	et	al.
5)	reported	on	atherosclerosis	imaging	techni-
ques	and	the	detection	of	patients	at	risk	of	ischemic	heart	dis-
ease	at	the	Bethesda	Conference	34.	They	concluded	that	a	
valuable	screening	test	should	have	the	following	character-
istics:	1)	identify	both	high-	and	low-risk	groups	accurately;	
2)	enhance	the	identification	of	high-risk	individuals,	3)	re-
sult	in	a	favorable	impact	on	disease	outcomes;	4)	be	rela-
tively	risk	free;	5)	be	cost-effective	when	compared	to	the	cur-
rent	screening	modalities;	and	6)	educate	the	public	concerning	
atherosclerosis	and	vascular	disease	risk.
In	conclusion,	before	embracing	CCTA	as	a	routine	screen-
ing	procedure,	the	potential	benefits	of	screening	must	be	
shown	to	outweigh	the	potential	harmful	effects,	and	further	
studies	supporting	a	correlation	between	plaque	progression	
imaging	and	future	cardiovascular	events	are	needed.
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